We designed the peptide ReACp53 to halt aggregation of p53 in cells
ReACp53 rescues p53 transcription of target genes and restores apoptosis
In vivo ReACp53 halts progression and shrinks tumors bearing aggregation-prone p53
p53 aggregation in cancer is a target for therapy with ReACp53 as a lead compound